IP Library Granted Patent US 10,626,358
Granted Patent B2
US 10,626,358 · App. 14/776,038 · Granted Apr 21, 2020

Systems and methods for tissue processing and preparation of cell suspension therefrom

Inventors: Andrew Perry Quick (Valencia, CA); David Allen Fencil (Valencia, CA); William Ford Dolphin (Topanga, CA)
Assignee: AVITA MEDICAL LTD
C12M21/08C12M45/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,626,358
App. No.
14/776,038
Granted
Apr 21, 2020
Kind
B2
Abstract

The present invention provides for methods and at least partially automated devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. Tissue regeneration in humans is extremely limited and constitutes a major challenge to the repair of damaged organ function. Wound treatment is a typical area where tissue regeneration is required. Wounds (lacerations or openings) in mammalian tissue can result in tissue disruption and coagulation of the microvasculature at the wound face.

Claims (34)

1. A system for cell harvesting and transplant, comprising:

a cartridge for processing a tissue, the cartridge comprising a tissue processing chamber, a disintegrator situated therein on which the tissue sits, a cap coupled to the tissue processing chamber, and a cell collection chamber separated from the tissue processing chamber by the disintegrator; and

a programmable console for removably housing the cartridge, wherein the console comprises a disintegrating member, an actuating mechanism, and a processor for controlling the actuating mechanism such that the disintegrating member exerts compression and a rotational force on the tissue through the cap without the disintegrating member contacting the tissue, thereby mechanically dissociating the tissue,

wherein after dissociating the tissue and passing the dissociated tissue through the disintegrator, a cell suspension is collected in the cell collection chamber.

2. The system of claim 1 , wherein the cartridge further comprises a container for providing a solution comprising a chemical reagent, wherein the chemical reagent is capable of breaking down extracellular matrix in the tissue.

3. The system of claim 2 , wherein the console further comprises a pressurizing mechanism for driving the solution out of the container and into the tissue processing chamber, thereby chemically dissociating the tissue therein.

4. The system of claim 1 , wherein the cartridge further comprises a first packet for providing an enzyme solution and a second packet for providing a buffer solution, both packets in fluid communication with the tissue processing chamber, wherein the enzyme solution breaks down extracellular matrix in the tissue thereby chemically dissociating the tissue, and wherein the buffer solution washes the dissociated tissue and suspends cells in the cell suspension.

5. The system of claim 4 , wherein the first packet has a first and a second container separated by a breakable seal, the first container containing sterile water and the second container containing lyophilized enzyme powder, wherein when the seal is broken, the lyophilized enzyme powder meets the sterile water and dissolves therein.

6. The system of claim 1 , wherein the cap is removably placed on or hinged to the tissue processing chamber and comprises a seal including a flexible portion for sealing the tissue processing chamber.

7. The system of claim 6 , wherein the seal has a first side and a second side, wherein the first side faces the tissue processing chamber and has a working surface, wherein the second side faces the disintegrating member, and wherein when the disintegrating member is actuated and placed upon the second side, the working surface is in contact with the tissue placed in the tissue processing chamber such that the compression and the rotational force is applied through the seal.

8. The system of claim 1 , wherein the cartridge further comprises at least one supplying container for providing an exogenous agent.

9. The system of claim 8 , wherein the exogenous agent is a heat shock protein or a fragment thereof, hyaluronic acid, platelet-enriched plasma, a growth factor, adipose stem cells, or any combination of the foregoing.

10. The system of claim 1 , wherein the disintegrating member is a reciprocating-rotating member, and the disintegrator is a mesh, screen, grid, blade, or any combination thereof.

11. The system of claim 1 , wherein the cartridge further comprises another disintegrating member situated in the tissue processing chamber.

12. The system of claim 1 , wherein the cartridge further comprises a mechanism for balancing pressure during fluid movement, wherein preferably the mechanism is an antimicrobial filter or a bore tortuous path.

13. The system of claim 1 , wherein a disposable applicator is removably in fluid communication, directly or indirectly, with the cell collection chamber and capable of receiving the cell suspension therefrom.

14. The system of claim 13 , wherein the disposable applicator is capable of dispensing, spraying or dripping the cell suspension therein onto a recipient site or a scaffold.

15. The system of claim 13 , wherein an outer surface of the disposable applicator is sealed in a sterile packaging before transport to a sterile field for cell transplant.

16. The system of claim 1 , further comprising a custom control software for directing the processor.

17. The system of claim 1 , being connected to an external computer for collecting and processing data.

18. The system of claim 1 , wherein the cartridge further comprises a mechanism for providing motive power to supply a mechanical force and/or a chemical reagent to the tissue.

19. The system of claim 1 , further comprising a support for receiving the cell suspension, wherein the support, after receiving the cell suspension, is presented for transplant or culturing.

20. The system of claim 19 , wherein the support is a matrix, a scaffold, a dressing, or any combination thereof.

21. The system of claim 19 , wherein the support is solid, semi-solid, porous or fragmented.

22. A method of cell harvesting and transplant using the system of claim 1 , comprising:

placing the tissue in the tissue processing chamber;

directing the console to actuate the disintegrating member; and

retrieving a disposable applicator having the cell suspension therein.

23. A method of cell harvesting and transplant using the system of claim 1 , comprising:

placing the tissue in the tissue processing chamber;

directing the processor in the console so as to supply a mechanical force and/or chemical reagent to the tissue; and

retrieving the cell suspension.

24. The system of claim 1 , wherein the cartridge further comprises a filter situated between the disintegrator and the cell collection chamber, for filtering the processed tissue to remove large aggregates.

25. The system of claim 1 , wherein the cartridge further comprises a filter situated downstream from the cell collection chamber, for filtering the cell suspension to remove large aggregates.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Jan 14, 2026
From: ORCO IV LLC
To: AVITA MEDICAL AMERICAS, LLC
Reel/Frame 073473/0540 →
SECURITY INTEREST Recorded Jan 13, 2026
From: AVITA MEDICAL, INC.; AVITA MEDICAL AMERICAS, LLC
To: PERCEPTIVE CREDIT HOLDINGS V, LP
Reel/Frame 073458/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2024
From: ORCO IV LLC
To: AVITA MEDICAL PTY LIMITED
Reel/Frame 066960/0046 →
SECURITY INTEREST Recorded Apr 1, 2024
From: AVITA MEDICAL AMERICAS, LLC
To: ORCO IV LLC
Reel/Frame 066960/0144 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2024
From: AVITA MEDICAL PTY LTD.
To: AVITA MEDICAL AMERICAS, LLC
Reel/Frame 066953/0770 →
SECURITY INTEREST Recorded Dec 13, 2023
From: AVITA MEDICAL PTY LIMITED
To: ORCO IV LLC
Reel/Frame 065856/0614 →
CHANGE OF NAME Recorded Sep 13, 2021
From: AVITA MEDICAL LTD
To: AVITA MEDICAL PTY LIMITED
Reel/Frame 057497/0166 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME FROM "AVITA MEDICAL LTD." TO "AVITA MEDICAL LTD" PREVIOUSLY RECORDED ON REEL 037086 FRAME 0079. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 27, 2018
From: QUICK, ANDREW PERRY; FENCIL, DAVID ALLEN; DOLPHIN, WILLIAM FORD
To: AVITA MEDICAL LTD
Reel/Frame 047649/0042 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2018
From: QUICK, ANDREW PERRY; FENCIL, DAVID ALLEN; DOLPHIN, WILLIAM FORD
To: AVITA MEDICAL LTD
Reel/Frame 047594/0015 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2015
From: QUICK, ANDREW PERRY; FENCIL, DAVID ALLEN; DOLPHIN, WILLIAM FORD
To: AVITA MEDICAL LTD.
Reel/Frame 037086/0079 →
Priority Claims (1)
AU 2013205148 · Apr 13, 2013 · national
Continuity (2)
Provisional Application 61783422 · Mar 14, 2013
Related Publication 20160024450A1 · Jan 28, 2016
Cited By (4)
US 1,112,812 US 12,270,019 US 12,281,298 US 12,570,949